Are Circulating Immune Cells a Determinant of Pancreatic Cancer Risk? A Prospective Study Using Epigenetic Cell Count Measures.
Katzke VA, Le Cornet C, Mahfouz R, Brauer B, Johnson T, Canzian F, Rebours V, Boutron-Ruault MC, Severi G, Schulze MB, Olsen A, Tjønneland A, Overvad K, Crous-Bou M, Molina-Montes E, Amiano P, Huerta JM, Ardanaz E, Perez-Cornago A, Masala G, Pala V, Tumino R, Sacerdote C, Panico S, Bueno-de-Mesquita B, Vermeulen R, Sund M, Franklin O, Christakoudi S, Dossus L, Weiderpass E, Olek S, Kaaks R.
Katzke VA, et al. Among authors: franklin o.
Cancer Epidemiol Biomarkers Prev. 2021 Dec;30(12):2179-2187. doi: 10.1158/1055-9965.EPI-21-0169. Epub 2021 Sep 20.
Cancer Epidemiol Biomarkers Prev. 2021.
PMID: 34548327